Please provide your email address to receive an email when new articles are posted on . For the two-part UNIVERSE study, 12 children who underwent the Fontan procedure were enrolled in a single-arm ...

PHILADELPHIA — In a phase 3 study, the phosphodiesterase-5 (PDE-5) inhibitor udenafil (Mezzion Pharma) did not improve the primary end point of oxygen consumption at peak exercise, but was associated ...

The phase 3 UNIVERSE study evaluated rivaroxaban oral suspension in patients aged 2 to 8 years with single ventricle physiology who had the Fontan procedure. New data were announced from a phase 3 ...

Patients with Fontan circulatory failure face higher mortality risk while awaiting or after undergoing heart transplantation, if they have certain health complications, according to a multi-center ...

A multi-center study has identified critical risk factors that increase the likelihood of death in children with a heart defect who are awaiting or have recently undergone heart transplantation, ...

Philadelphia, April 24, 2024 – As patients with congenital heart diseases live longer, researchers are attempting to understand some of the other complications they may face as they age. In a new ...

The lifesaving surgery used to treat children with single ventricle heart disease, the Fontan procedure, can pose serious health complications throughout life. The American Heart Association, devoted ...

Children's Hospital Colorado (Children's Colorado) successfully performed the hospital's first-ever heart and liver dual organ transplant, with support from dozens of team members across 25 different ...